OK Biotech Co., Ltd.

TWSE:4155 Rapporto sulle azioni

Cap. di mercato: NT$3.6b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

OK Biotech Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Jia De Lai

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO0.1%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneless than a year

Aggiornamenti recenti sulla gestione

Recent updates

OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings

Aug 20
OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings

OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Apr 26
OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

Apr 04
Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Mar 17
OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Mar 01
Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

Feb 15
Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

A Look At OK Biotech's (TPE:4155) Share Price Returns

Jan 31
A Look At OK Biotech's (TPE:4155) Share Price Returns

We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Jan 17
We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Jan 03
Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Dec 21
Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Dec 08
Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

Nov 23
Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

AMMINISTRATORE DELEGATO

Jia De Lai

no data

Mandato

Jia De Lai serves as the Chairman and Managing Director of OK Biotech Co., Ltd and serves as its Manager.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Jia De Lai
Managerno dataNessun dato0.15%
NT$ 5.3m
Qi Zheng Hou
CFO, Financial Managerless than a yearNessun datoNessun dato
De Zhang
Chief Operating Officerno dataNessun datoNessun dato
De Wang
Business Office Associateno dataNessun datoNessun dato
Yuan Chen
Independent Directorno dataNessun datoNessun dato
Yun Xie
Independent Directorno dataNessun datoNessun dato
Chao Jiang
Independent Directorno dataNessun datoNessun dato
De Zhang
Directorno dataNessun datoNessun dato
Ching Piao Chen
Directorless than a yearNessun datoNessun dato
Chen Kang Wang
Directorless than a yearNessun datoNessun dato
Chin Yuan Hsu
Directorless than a yearNessun datoNessun dato
Shin Wan Lan
Directorless than a yearNessun datoNessun dato

0.08yrs

Durata media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 4155 non è considerato esperto (durata media del mandato 0.1 anni), il che suggerisce un nuovo consiglio.